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Percutaneous catheter ablation is an established rhythm
control strategy for the treatment of atrial ﬁbrillation
(AF).1,2 Recent clinical trials show that catheter ablation of
atrial ﬁbrillation reduces the risk of recurrence of sympto-
matic AF, atrial ﬂutter, or atrial tachycardia, and may also
reduce subsequent hospitalizations and improve quality of
life compared to antiarrhythmic drug therapy.3,4 Catheter
ablation has garnered a class I recommendation for patients
with symptomatic paroxysmal AF who are refractory or
intolerant to at least one class I or III antiarrhythmic
medication, and has a class IIa recommendation as a
reasonable initial rhythm control strategy in the 2014 guide-
lines published by the American College of Cardiology/
American Heart Association/Heart Rhythm Society.5
Catheter ablation for AF is widely regarded as a safe
procedure. A recently published retrospective analysis of AF
catheter ablation (performed in 83,236 patients enrolled in a
total of 192 published clinical trials) reported an overall
periprocedural complication rate of 2.9%. The majority of the
complications were vascular in nature with an incidence of
1.4%.6 Gastrointestinal (GI) complications following catheter
ablation for AF are exceedingly rare. The most serious GI
complication after catheter ablation is formation of an
atrioesophageal ﬁstula, which has a very low incidence
(0.03%-0.1% of cases). However, atrioesophageal ﬁstulae
can lead to potentially life-threatening sequelae including
catastrophic bleeding, septicemia, cerebrovascular accidents,
and air embolism, and carry a mortality rate exceeding 80%.7,8KEYWORDS Acute gastric hypomotility; Radiofrequency ablation; Esopha-
geal temperature monitoring
ABBREVIATIONS AF ¼ atrial fibrillation; 3D ¼ 3-dimensional; EPS ¼
electrophysiology study; GI ¼ gastrointestinal; ICE ¼ intracardiac
echocardiogram; LET ¼ luminal esophageal temperature; PVI ¼
pulmonary vein isolation; RF ¼ radiofrequency; TEE ¼
transesophageal echocardiogram
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complications that affect the upper GI tract following catheter
ablation for AF. One of these complications is periesophageal
vagal nerve injury, which leads to acute onset of upper GI
symptoms that typically develop within hours after ablation.
Clinicians need to be aware of and recognize this complica-
tion, quickly distinguish it from other potentially life-
threatening conditions such as esophageal perforation or
bowel obstruction, and institute an appropriate treatment plan.
Case report
A 56-year-old man with hypertension, type 2 diabetes
mellitus, hyperlipidemia, obstructive sleep apnea, chronic
kidney disease, and diastolic heart failure was admitted for an
elective catheter ablation for recurrent paroxysmal AF. A
transesophageal echocardiogram (TEE) with echo-contrast
performed 2 months prior demonstrated a thrombus within
the left atrial appendage, and he was prescribed rivaroxaban
at a renal-adjusted dose of 15 mg daily. The night prior to the
procedure, rivaroxaban was discontinued and a weight-based
continuous infusion of unfractionated heparin was started
periprocedurally. Repeat TEE showed no residual thrombus
in the left atrial appendage. A commercially available non-
deﬂectable transesophageal temperature probe (Level 1
Acoustascope® with temperature sensor ES400-18; Smiths
Medical ASD, Inc, Rockland, MA) was inserted to monitor
luminal esophageal temperature (LET). A 10F SOUNDSTAR®
(Biosense Webster, Diamond Bar, CA) intracardiac echocar-
diogram (ICE) catheter was placed in the right atrium for
anatomic mapping of the left atrium, left atrial appendage,
and pulmonary veins, and under ICE guidance a double
transseptal puncture was performed using a Brockenbrough
needle assembly. Three-dimensional (3D) mapping was
performed using a 7F variable-curve Lasso catheter (Biosense
Webster, Diamond Bar, CA) inserted through an SL1 sheath
(St. Jude Medical, St. Paul, MN), and the CARTO® 3
mapping platform was used along with the CARTOSOUND®
module, which enabled integration of the ICE images with
the 3D mapping images (Figure). Pulmonary vein isolation
(PVI) was performed using an 8F bidirectional 3.5-mm-tip
THERMOCOOL® SF catheter (Biosense Webster, Diamondpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
▪ Periesophageal vagal nerve injury manifests as
acute onset of nausea, vomiting, abdominal pain
and distension within 3–12 hours after pulmonary
vein isolation for ablation of atrial ﬁbrillation (AF).
▪ This condition should be rapidly differentiated
from other serious gastrointestinal complications
after AF ablation, such as esophageal perforation
or development of atrioesophageal ﬁstula.
▪ Most cases will respond to conservative
management, which includes complete bowel rest,
mechanical decompression of the upper
gastrointestinal tract, and oral or intravenous
prokinetic agents.
▪ Various strategies can be employed to reduce the
risk of periesophageal vagal nerve injury during AF
ablation; these include avoiding ablation of the
posterior left atrial wall, use of irrigated-tip
catheters, reduction in power output and/or
duration of delivery of radiofrequency energy, and
use of esophageal temperature monitoring devices.
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usable length) Agilis™NxT sheath (St Jude Medical, St Paul,
MN), with bidirectional steering to facilitate maneuverability,
improve access to difﬁcult-to-reach sites, and assure optimal
tissue contact in the absence of direct quantitative contactFigure Relationship of the lower esophagus, posterior left atrium, and pulmonary
(LA) and the esophagus (ESO) as it courses close to the posterior atrial wall in our
pulmonary veins, and the anatomic relationship between the esophagus and the abl
esophagus to the ostia of the left upper and lower pulmonary veins. RSPV¼ right s
superior pulmonary vein; LIPV ¼ left inferior pulmonary vein.force measurement. Radiofrequency (RF) energy delivery to
the posterior wall was initiated at 20 W and titrated
(maximum of 35 W) until a 10 Ω drop in impedance and
an 80% reduction in electrogram size was achieved. Energy
delivery at other sites was limited to 35–50 W. Energy
delivery to lesions near the esophagus was limited to r30
seconds and was stopped immediately if the LET increased
by 1oC above baseline. No esophageal temperature record-
ings of more than 40oC were recorded during the entire
procedure. An empiric bidirectional cavo-tricuspid isthmus
ablation was also performed. The patient tolerated the
procedures well, and he was admitted to the cardiac intensive
care unit for postprocedure monitoring.
About 6 hours after the procedure, the patient developed
intractable nausea and vomiting that was unresponsive to
intravenous ondansentron and trimethobenzamide. In addition,
he developed generalized abdominal pain and distension. On
inquiry, he denied any GI symptoms prior to the ablation
procedure. Physical examination revealed tenderness in the
epigastric and periumbilical regions and hypoactive bowel
sounds throughout the abdomen. An abdominal radiograph
demonstrated prominent gas-ﬁlled "stacked"-appearing loops of
small bowel consistent with early ileus. A computed tomo-
graphic scan of the chest did not demonstrate any air or swelling
within the mediastinum. A nasogastric tube was inserted and
connected to intermittent suction, which reduced his vomiting
and abdominal pain, but the nausea and abdominal distension
persisted. Gastroenterological consultation was requested, and
he was started on intravenous erythromycin 3 mg/kg thrice
daily, along with intravenous metoclopramide 5 mg every 6
hours as needed. Over the next 48 hours, his nausea andveins in our patient.A: Intracardiac echocardiogram image of the left atrium
patient. B: Posterior view of the 3-dimensional map of the left atrium and the
ation sites around the ostia of the pulmonary veins. Note the proximity of the
uperior pulmonary vein; RIPV¼ right inferior pulmonary vein; LSPV¼ left
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started on day 5, and the patient was advanced gradually to a
regular diet by day 7. His GI symptoms had completely resolved
at the time of discharge on postprocedural day 10. Erythromycin
was continued orally at a dose of 400 mg thrice daily for a total
of 4 weeks. Over the next 16 months of follow-up, the patient
has not had any recurrence of GI symptoms and has also
remained free of recurrent AF.
Discussion
The incidence of periesophageal vagal nerve injury is much
lower than other complications after catheter ablation for AF,
such as femoral pseudoaneurysm, arteriovenous ﬁstulae,
bleeding, pulmonary vein stenosis, pericardial effusion,
cardiac tamponade, and cerebrovascular events. Periesopha-
geal vagal nerve injury clinically presents with symptoms of
acute gastric hypomotility and, in some cases, acute pyloric
spasm as seen on abdominal imaging or by endoscopy. Most
information about periesophageal vagal nerve injury after
catheter AF ablation is obtained from case reports and case
series, and the incidence of this complication may be as high
as 0.3% following catheter AF ablation.9–12
The esophagus follows a variable course along the
posterior aspect of the left atrium owing to displacement
by the aortic arch, and the thickness of the esophageal wall
adjacent to the left atrium varies from 1.5 to 4.5 mm. The
posterior left atrial wall also varies in thickness, being
thickest adjacent to the coronary sinus and thinnest superi-
orly. Behind the left atrial wall exists a layer of ﬁbrous
parietal pericardium and ﬁbroadipose tissue of uneven
thickness. Within the fat pad and in contact with the posterior
left atrial wall through the parietal pericardium, branches of
the left vagus nerve descend along the anterior aspect of the
esophageal wall, before forming a plexus with branches from
the right vagus nerve around the esophagus.13 The space
between the esophagus and the posterior wall of the left
atrium is highly variable owing to differences in thickness of
the connective tissue of the parietal pericardium and of the
ﬁbroadipose tissue between the esophagus and left atrium,
and this may lead to variations in the vulnerability of the
periesophageal nerve ﬁbers to injury during application of
RF energy. The periesophageal vagal nerve plexus controls
gastric peristalsis, function of the pyloric sphincter, and
gastric motility, and injury to this plexus can lead to acute
gastric hypomotility and pyloric spasm.
Many theories exist about the pathophysiology of peri-
esophageal vagal nerve injury during catheter ablation, but
none have been substantiated in clinical studies. PotentialTable 1 Possible strategies to reduce the risk of periesophageal nerve
▪ Avoid ablation of the posterior left atrial wall, use of a “box-isolation
▪ Use irrigated-tip catheters for radiofrequency (RF) ablations
▪ Reduction in RF power output (25–30 watts)
▪ Reduction in the duration of delivery of RF energy (r30 seconds)
▪ Use of esophageal temperature monitoring—stop ablation if luminal
▪ Consider preprocedural imaging studies to determine the distance be
▪ Consider screening of high-risk individuals for presence of reﬂux esopmechanisms of injury include direct thermal injury to the
esophageal wall due to conductive or convective transfer of
RF energy through the thin-walled left atrium, ischemic
injury to the esophageal wall, and inﬂammatory changes
within the esophageal wall. Some experts opine that a
combination of thermal and ischemic insults leads to
progressive esophageal wall damage following catheter
ablation. Another possible mechanism for progression of
esophageal lesions after initial thermal injury from RF
ablation is the reﬂux of acidic stomach contents bathing
the lesion.14,15 A small study showed that compared to
baseline, both fasting and postprandial electrogastrogram
abnormalities and bradygastria increased immediately after
electrophysiology study (EPS) and ablation in patients with
AF, but these changes were not observed in the patients
undergoing EPS and ablation for non-AF conditions.16
Early studies in animals compared the effects of RF energy
vs cryoablation on the incidence and time course of esoph-
ageal injury. Cryoablation and RF ablation created similar
acute and chronic lesion dimensions in the esophagus, but
cryoablation was associated with a signiﬁcantly lower risk of
partial- to full-wall esophageal ulceration seen by histology
compared with RF ablation.17 Ahmed and colleagues18 noted
a 17% incidence of esophageal ulceration following balloon
cryoablation for PVI,18 but studies comparing the effects of
cryoablation vs RF ablation on the development of perieso-
phageal vagal nerve injury are currently lacking.
Prevention
Although there is no established approach for avoiding
injury to the periesophageal vagal nerve ﬁbers, the risks
can be minimized by using the same techniques for prevent-
ing other esophageal complications. Schmidt and col-
leagues19 stopped energy delivery if there was sudden
increase in microbubble density within the left atrium seen
with ICE. One widely used strategy to limit the extent of
esophageal injury is the use of esophageal temperature
monitoring utilizing commercially available or improvised
temperature probes. Delivery of RF energy should be
discontinued when the esophageal temperature increases
signiﬁcantly, and most centers stop energy delivery if the
esophageal temperature approaches 38.51C–421C.20–22 It
should be noted that LET may continue to rise further even
after RF cessation. Another approach is to avoid delivering
RF energy to the left atrial posterior wall, which is adjacent
to the esophagus, with measures such as using a “box-
isolation approach” PVI or reducing maximum energy
output during ablation of the left atrial posterior wall. Musatinjury during catheter ablation of atrial ﬁbrillation
” approach for atrial ﬁbrillation ablation
esophageal temperature approaches 421C
tween the posterior left atrial wall and the esophagus
hagitis
Table 2 Clinical management of periesophageal nerve injury following catheter ablation of atrial ﬁbrillation
▪ Complete bowel rest (nothing by mouth) until symptoms subside
▪ Decompression of upper gastrointestinal tract using a nasogastric tube connected to intermittent or continuous suction
▪ Intravenous prokinetic agents (erythromycin 3 mg/kg 3 times daily as needed)
▪ Oral prokinetic agents if patients can tolerate oral intake (mosapride, metoclopramide)
▪ For persistent symptoms:
Oral erythromycin 400 mg thrice daily for up to 4 weeks
Injection of botulinum toxin A into the pyloric sphincter
Surgical diversion (esophageojejunal anastomosis)
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distance to the esophageal lumen to avoid LET increase
during RF energy delivery at the posterior left atrium and
pulmonary vein ostium was 24 mm, with a sensitivity of 90%
and a negative predictive value of 98%. The esophagus may
also be protected by mechanical displacement of the lower
esophagus as it courses close to the posterior left atrial wall.
Chugh and colleagues24 used an endoscope to mechanically
displace the esophagus by up to 2.4 cm during AF ablation,
while Koruth and colleagues25 used an endotracheal stylet
within a chest tube, achieving an average displacement of
2.8 cm. Unfortunately, 60% of patients had evidence of
trauma as a consequence of esophageal deviation in the latter
study. Since thermal energy transmission to the esophageal
wall is thought to be a major contributor, the esophagus may
be protected using a cooling mechanism. Berjano and
colleagues26 reported the theoretical effectiveness of esoph-
ageal cooling with a cooled intraesophageal balloon, and a
pilot study of 8 patients reported that using an irrigated
intraesophageal balloon during ablation on the posterior wall
(with concurrent LET monitoring) signiﬁcantly reduced
baseline and maximal esophageal temperature during abla-
tion.27 However, further studies are needed to determine the
feasibility, safety, and efﬁcacy of this strategy in reducing the
risk of esophageal injury during ablation procedures.
Another strategy proposed in the literature is to screen for
esophageal ulcerations in certain high-risk patients, and to
treat them with antireﬂux medications if esophageal ulcer-
ation is discovered. Although prophylactic use of acid
suppression therapy with proton-pump inhibitors or H2
antagonists either before or after AF ablation may be
considered, the proper time for initiation and duration of
therapy have not been clearly established.28 The various
strategies to reduce the risk of periesophageal nerve injury
during catheter ablation of AF are summarized in Table 1.Treatment
The clinical management of this complication is usually
conservative. The patient should be placed on complete
bowel rest for 2–14 days based on the persistence of clinical
symptoms, and then small, low-fat, and low-ﬁber meals
should be gradually introduced. Intravenous erythromycin,
which increases gastrointestinal motility, probably by acting
as a motilin agonist, may be effective in restarting gastric
movement during acute episodes of gastric stasis when oral
intake is not tolerated. Several studies have reportedimprovement in the severity and duration of symptoms from
periesophageal vagal nerve injury with the use of intra-
venous erythromycin.9,29 Oral mosapride or metoclopramide
are also effective in alleviating the symptoms in some
patients after they are able to eat and tolerate oral medi-
cations. Injection of botulinum toxin A into the pyloric
sphincter has been reported to improve the delayed gastric
emptying in patients with gastroparesis after AF ablation, but
1 controlled study reported that this improvement was
similar to placebo.30 In the occasional patient with persis-
tence of symptoms with evidence of gastric hypomotility or
pyloric spasms beyond 3–6 months, invasive treatment
modalities such as injection of botulinum toxin A into the
pyloric sphincter or surgical diversion such as an esoph-
ageojejunostomy may be needed.9 The approach to manage-
ment of patients with periesophageal nerve injury following
catheter ablation of AF is summarized in Table 2.Conclusions
Periesophageal vagal nerve injury is being increasingly
identiﬁed in patients who have undergone catheter ablation
for AF. The clinical presentation is characterized by acute
onset of symptoms of gastric hypomotility (nausea, vomiting,
abdominal pain and distension) that usually develop within 6–
24 hours following the ablation, and may be accompanied by
evidence of pyloric spasm as demonstrated by upper GI
radiography or endoscopy. Proposed causative mechanisms
include thermal injury to the esophageal wall, inﬂammation,
and ischemic injury. Clinical experience is limited to small
case series performed in high-volume centers and large multi-
center studies investigating the effects of changing procedural
settings (such as RF energy output, duration of RF delivery,
number and location of ablation sites in particularly vulnerable
areas such as the posterior left atrial wall), and preventive
strategies (endoscopic displacement of the esophagus, esoph-
ageal cooling using irrigated balloons) are lacking. LET
monitoring using an esophageal temperature probe may
potentially help reduce the risk of periesophageal nerve injury,
but currently there are no evidence-based guidelines on how to
reduce this risk. Treatment is essentially supportive and
consists of complete bowel rest, use of antiemetics and GI
prokinetic agents, and acid suppression therapies in patients
with known reﬂux esophagitis. The majority of patients will
have complete resolution of symptoms within 1–3 weeks,
while a small minority of patients may require additional,
invasive treatments for persistent symptoms.
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